These data indicated a potential mechanism for the antitumor activity of GANT61 which might inhibit viability of T-cell lymphoma cells at least partially by down-regulating p-STAT3 and SOCS3. Here, SOCS3 is linked to T-cell non-Hodgkin lymphoma.